Hot Pursuit     05-Aug-21
Alembic Pharma receives final approval for OCD treatment drug
Alembic Pharmaceuticals on Thursday announced that it has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Clomipramine Hydrochloride Capsules.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Anafranil Capsules of SpecGX LLC. Clomipramine Hydrochloride Capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

According to IQVIA, Clomipramine Hydrochloride Capsules USP have an estimated market size of $32 million for twelve months ending June 2021. Alembic has a cumulative total of 149 ANDA approvals from USFDA.

Shares of Alembic Pharma were trading 1.07% lower at Rs 778 on BSE.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

Previous News
  Market near day's high; metal shares rally for 3rd day
 ( Market Commentary - Mid-Session 01-Jul-24   12:34 )
  Alembic Pharma spurts on USFDA nod for leukemia drug
 ( Hot Pursuit - 01-Jul-24   11:06 )
  Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
 ( Corporate News - 16-Feb-23   15:25 )
  Alembic Pharma gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 26-Dec-22   09:44 )
  Alembic receives USFDA approval for Fulvestrant Injection
 ( Corporate News - 26-Dec-22   09:10 )
  Alembic Pharma gains on USFDA nod for Mesalamine capsules
 ( Hot Pursuit - 02-Nov-22   12:28 )
  Alembic Pharmaceuticals gains on USFDA nod for bronchoconstriction drug
 ( Hot Pursuit - 11-May-22   12:22 )
  Alembic Pharmaceuticals standalone net profit rises 29.63% in the September 2020 quarter
 ( Results - Announcements 22-Oct-20   17:07 )
  Alembic Pharma subsidiary receives final approval for lidocaine cream
 ( Hot Pursuit - 12-Apr-22   10:57 )
  Alembic Pharmaceuticals' subsidiary gets USFDA approval
 ( Hot Pursuit - 12-Apr-22   10:55 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets
 ( Corporate News - 01-Jul-24   10:44 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top